The Patent Finder

Specgx LLC

123 patents currently held · Updated Nov 21, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
50
Ending by 2030
Mar 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 2 to 6, 2026 · next Dec 2
  • 2 fees due Mar 1 to 8, 2027 · next Mar 1
  • 1 fee due Apr 15, 2027
    The maintenance fee for Systems and Methods for High Humidity Curing Within Tablet Coating System (US 10,441,508) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
  • 3 fees due May 10 to 26, 2027 · next May 10
  • 1 fee due Sep 29, 2027
    The maintenance fee for Reductive Amination of 6-Keto Morphinans by Catalytic Hydrogen Transfer (US 9,296,699) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
  • 2 fees due Oct 5 to 21, 2027 · next Oct 5
  • 1 fee due Nov 17, 2027
    The maintenance fee for PROCESS FOR THE PREPARATION OF RADIOIODINATED 3-Fluoropropyl-NOR-Beta-CIT (US 9,339,565) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,667,564Processes for Preparing MORPHINAN-6-ONE Products with Low Levels of Alpha, Beta-Unsaturated Ketone Compounds
In force
 · Low confidence
In forceLow confidence
US 8,748,611Processes for Preparing MORPHINAN-6-ONE Products with Low Levels of Alpha Beta-Unsaturated Compounds
In force
 · High confidence
In forceHigh confidence
US 7,622,586Opiate Intermediates and Methods of Synthesis
In force
 · High confidence
In forceHigh confidence
US 7,511,060Opiate Intermediates and Methods of Synthesis
In force
 · High confidence
In forceHigh confidence
US 7,834,184Opiate Intermediates and Methods of Synthesis
In force
 · High confidence
In forceHigh confidence
US 9,415,044Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
In force
 · Low confidence
In forceLow confidence
US 8,022,181Composition and Method for the Release of Protected Peptides from a Resin
In force
 · High confidence
In forceHigh confidence
US 8,669,366Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
In force
 · High confidence
In forceHigh confidence
US 7,714,063Solid Support for Fmoc-Solid Phase Synthesis of Peptides
In force
 · High confidence
In forceHigh confidence
US 8,115,002Preparation of Substituted MORPHINAN-6-ONES and Salts and Intermediates Thereof
In force
 · High confidence
In forceHigh confidence
10 of 123 patents shown.
Pro members see all 123.
Pro members: see all 123 patents
Also on record, not counted in the 123: 1 patent in force now held by others · 2 lapsed for an unpaid fee · 10 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 6 abandoned

Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
19/246,191Preparation of Sufentanil Citrate and Sufentanil BaseJun 23, 2025Pending
18/712,628Injectable Sustained Release Pharmaceutical CompositionNov 22, 2022Pending
17/091,109Preparation of Sufentanil Citrate and Sufentanil BaseNov 6, 2020Abandoned
16/927,497PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDSJul 13, 2020Abandoned
16/549,718PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDSAug 23, 2019Abandoned
16/529,323Zero-Order Modified Release Solid Dosage FormsAug 1, 2019Abandoned
16/219,253One Step Milling Process for Preparing Micronized Paliperidone EstersDec 13, 2018Abandoned
16/002,190Immediate Release, Abuse Deterrent Pharmaceutical CompositionsJun 7, 2018Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited